The "APP Gene Cerebral Amyloid Angiopathy APP Related Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the APP gene, which can lead to cerebral amyloid angiopathy (CAA). This condition is characterized by the accumulation of amyloid proteins in the walls of the cerebral arteries, leading to a range of neurological problems, including an increased risk of hemorrhagic stroke. The test is critical for individuals with a family history of CAA or related symptoms, as it can provide essential information for early diagnosis and management of the condition. The cost of the test is 4400 AED, reflecting the comprehensive analysis and expertise required to accurately identify the presence of APP gene mutations.
The PRKCH gene, associated with the protein kinase C eta type, has been linked to an increased susceptibility to cerebral infarction, a type of ischemic stroke where blood flow to a part of the brain is obstructed, leading to brain tissue damage. Given the significant role genetics play in the risk of developing cerebral infarction, genetic testing for variations in the PRKCH gene can provide crucial information for individuals concerned about their stroke risk.
DNA Labs UAE offers a specialized genetic test focused on the PRKCH gene to assess an individual's susceptibility to cerebral infarction. This test is particularly beneficial for those with a family history of stroke or identified risk factors, enabling them to take preventive measures based on their genetic predisposition. The cost of the test is 4400 AED, which reflects the comprehensive analysis and personalized risk assessment provided.
By opting for this test, individuals can gain valuable insights into their genetic makeup, empowering them with the information needed to make informed health decisions. It's a proactive approach to health management, allowing for personalized preventive strategies to reduce the risk of cerebral infarction.
The GAD1 Gene Cerebral Palsy Type 1 Spastic Quadriplegic Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying genetic mutations associated with Type 1 Spastic Quadriplegic Cerebral Palsy. This condition, a form of cerebral palsy, is characterized by significant muscle stiffness and weakness in all four limbs, affecting an individual's ability to move and maintain balance and posture. The test focuses on mutations in the GAD1 gene, which have been linked to the development of this specific type of cerebral palsy.
Understanding the genetic underpinnings of cerebral palsy can provide crucial insights into the condition's etiology, potentially guiding treatment options and management strategies. This genetic test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accuracy and reliability of the results. Through a simple and minimally invasive process, DNA Labs UAE offers individuals and families the opportunity to gain valuable genetic information, paving the way for personalized care plans and interventions.
The KANK1 Gene Cerebral Palsy Type 2 Spastic Quadriplegic Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the KANK1 gene, which have been associated with Type 2 Spastic Quadriplegic Cerebral Palsy. This form of cerebral palsy is characterized by severe motor dysfunction affecting all four limbs, leading to muscle stiffness, reduced mobility, and coordination challenges. The test plays a crucial role in the early diagnosis and management of the condition, allowing for tailored interventions and support to improve the quality of life for affected individuals. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test is priced at 4400 AED, reflecting the sophisticated technology and expertise involved in identifying the genetic underpinnings of this complex neurological disorder.
The CYP27A1 gene cerebrotendinous xanthomatosis genetic test is a specialized diagnostic tool used to identify mutations in the CYP27A1 gene, which are linked to cerebrotendinous xanthomatosis (CTX). CTX is a rare, inherited metabolic disorder characterized by abnormal storage of cholesterol and cholestanol in various tissues of the body, leading to neurological problems, premature atherosclerosis, cataracts, and xanthomas. The test involves analyzing the patient's DNA to detect mutations in the CYP27A1 gene, which is crucial for bile acid synthesis. Early diagnosis through genetic testing is vital for managing symptoms and preventing disease progression through appropriate treatments. This test is available at DNA Labs UAE, a leading facility in genetic diagnostics, at a cost of 4400 AED.
The "CIZ1 Gene Cervical Dystonia Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the CIZ1 gene, which have been associated with cervical dystonia. Cervical dystonia, also known as spasmodic torticollis, is a painful condition where the neck muscles contract involuntarily, causing the head to twist or turn to one side. It is the most common form of focal dystonia, and its exact cause is often unknown, but genetic factors are believed to play a significant role in some cases.
The test aims to provide individuals with a better understanding of their genetic predisposition to developing cervical dystonia by analyzing the CIZ1 gene for specific mutations. This information can be invaluable for early diagnosis, management, and treatment planning for those at risk or those already exhibiting symptoms of the disorder.
Offered at a cost of 4400 AED, the test at DNA Labs UAE represents an investment in personal health and well-being. The lab provides a comprehensive service, including detailed analysis and interpretation of results by genetic specialists. For patients and families affected by cervical dystonia, this test offers hope for more personalized and effective management strategies, potentially improving quality of life for those diagnosed with the condition.
The DYNC1H1 gene plays a critical role in the development and function of the peripheral nervous system. Mutations in this gene are associated with Charcot-Marie-Tooth disease axonal type 20 (CMT2O), a form of hereditary motor and sensory neuropathy. This condition is characterized by a progressive loss of muscle tissue and touch sensation across various parts of the body. The genetic test for CMT2O involves analyzing the DYNC1H1 gene to identify mutations that cause the disease. This testing is crucial for confirming the diagnosis, understanding the disease progression, and making informed decisions about management and treatment.
At DNA Labs UAE, the test for identifying DYNC1H1 gene mutations associated with Charcot-Marie-Tooth disease axonal type 20 is available. The cost of the test is 4400 AED. Conducted in a state-of-the-art laboratory by experienced geneticists, the test provides accurate and reliable results, offering crucial information for affected individuals and their families. Through this testing, it becomes possible to adopt a proactive approach in managing the condition, including early intervention strategies and genetic counseling for family planning.
The NSDHL Gene CHILD Syndrome Genetic Test is a specialized diagnostic tool designed to identify mutations in the NSDHL gene, which are associated with CHILD Syndrome (Congenital Hemidysplasia with Ichthyosiform erythroderma and Limb Defects). This rare genetic condition is characterized by distinctive skin abnormalities and limb defects affecting one side of the body. The test is crucial for accurate diagnosis, allowing for tailored management and care plans for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab. The laboratory employs advanced genetic sequencing techniques to meticulously analyze the NSDHL gene for any mutations that are indicative of CHILD Syndrome.
The cost of the NSDHL Gene CHILD Syndrome Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis required to ensure accurate results, providing essential information for affected families and their healthcare providers. By confirming a diagnosis, this test paves the way for supportive treatments and interventions, significantly impacting the quality of life for those diagnosed with CHILD Syndrome.
The NKX2-1 gene chorea hereditary benign genetic test is a specialized diagnostic tool used to identify mutations in the NKX2-1 gene, which are associated with hereditary benign chorea (HBC). HBC is a rare neurological disorder characterized by involuntary, non-repetitive, and flowing movements primarily affecting the limbs and face. This condition is generally non-progressive and symptoms may vary in severity among individuals.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The procedure involves collecting a DNA sample, typically through a blood draw, from which genetic material is extracted and analyzed for specific mutations in the NKX2-1 gene. This gene plays a crucial role in the development and function of the brain, lungs, and thyroid, explaining the diverse symptoms that can accompany the disorder, including respiratory and thyroid issues alongside the characteristic chorea.
The cost of the NKX2-1 gene chorea hereditary benign genetic test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test, the advanced technology used in the analysis, and the professional expertise required to accurately interpret the results. For individuals with a family history of HBC or those exhibiting symptoms, this test offers a critical pathway to confirming a diagnosis, understanding the risk of transmission to offspring, and accessing appropriate management and support strategies.
The VPS13A Gene Choreoacanthocytosis Genetic Test is a specialized diagnostic tool designed to detect mutations in the VPS13A gene, which are associated with choreoacanthocytosis, a rare neurological disorder. This condition is characterized by involuntary movements, muscle weakness, and abnormal red blood cells. The test is crucial for confirming a diagnosis, enabling early intervention and management of symptoms. Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the test costs 4400 AED. Through a simple blood sample, the test offers individuals and families critical insights into this genetic condition, facilitating informed healthcare decisions.
